322056 VO Introduction to Nanomedicine: Nucleic acid therapy and Bioimaging - M14 (2021W)
Labels
GEMISCHT
An/Abmeldung
Hinweis: Ihr Anmeldezeitpunkt innerhalb der Frist hat keine Auswirkungen auf die Platzvergabe (kein "first come, first served").
Details
Sprache: Englisch
Prüfungstermine
Lehrende
Termine
The lectures will be held in a digital format (on-line) via Moodle by using the 'Collaborate' tool.
All uploaded information/documents (e.g. files, data, etc.) are solely to be used for personal use of the course participant.
Owing to copyright rules and regulations, sharing or uploading of the above to any other platform or social platforms is strictly forbidden.
Time slot: 9:00-10:30 on all days except 16.12.21. On 16.12.21- 11:30-13:00
Please check moodle link of the course for updates.In case of any troubles with enrolment, please email haider.sami@univie.ac.at
Information
Ziele, Inhalte und Methode der Lehrveranstaltung
Art der Leistungskontrolle und erlaubte Hilfsmittel
Examination at the end of the course.
Mindestanforderungen und Beurteilungsmaßstab
Attending all the lectures, active participation in the course and performance in the examination.
Prüfungsstoff
Topics covered in the lectures.
Literatur
All required reading materials will be uploaded on the Moodle link of the course.
Zuordnung im Vorlesungsverzeichnis
MA23, A400
Letzte Änderung: Do 13.01.2022 09:49
Introduction to nanotechnology, nanomaterials and nanoscale (within the context of biotechnology and biopharmaceutics)- basic concepts and definitions.Introduction to nanomedicine (within the general context of biomedical applications and with special focus on nucleic acid therapy and bioimaging)- general concepts, definitions, claims and scope, pharmaceutical and biomedical applications, changing landscape of pharmaceuticals containing nanomaterials, nanomedicine/nanomaterial platforms for nucleic acid therapy and bioimaging applications, selected examples of nanomedicine platforms under pre-clinical trials/clinical trials/clinical use, biological challenges faced by nanomedicines, physicochemical and biological characterization techniques for relevant nanopharmaceutics.